Despite the near universal occurrence of activating codon 12 KRAS somatic variants in pancreatic cancer, there is considerable heterogeneity in the molecular make-up, MAPK/ERK pathway activation states, and clinical outcome in this disease. | Expression of the scaffold connector enhancer of kinase suppressor of Ras 1 CNKSR1 is correlated with clinical outcome in pancreatic cancer